Researchers are developing a new class of engineered live bacterial therapeutics to treat various human diseases. The engineered bacteria are being explored for their potential to treat a range of conditions, including mental health issues, metabolic and cardiovascular diseases, and certain types of cancer. Studies are also investigating the use of these bacteria to address specific health issues, such as liver-related brain dysfunction and phenylketonuria, by modifying their genetic makeup and metabolism.